UVRAG is found to be monoallelically mutated in human colon cancer, and UVRAG has been suggested to act by inhibiting the proliferation and tumorigenic activity of human colon cancer cells [50,51]. This evidence concerns the gene UVRAG and malignant colon neoplasm.